References
- Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol 2007; 8: 463-470. https://doi.org/10.1038/ni1454
- Day MJ, Henderson SM, Belshaw Z, Bacon NJ. An immunohistochemical investigation of 18 cases of feline nasal lymphoma. J Comp Pathol 2004; 130: 152-161. https://doi.org/10.1016/j.jcpa.2003.10.004
-
Felisberto R, Matos J, Alves M, Cabecadas J, Henriques J. Evaluation of Pax5 expression and comparison with BLA.36 and
$CD79{\alpha}cy$ in feline non-Hodgkin lymphoma. Vet Comp Oncol 2017; 4: 1257-1268. - Henderson SM, Bradley K, Day MJ, Tasker S, Caney SM, Hotston Moore A, Gruffydd-Jones TJ. Investigation of nasal disease in the cat-a retrospective study of 77 cases. J Feline Med Surg 2004; 6: 245-257. https://doi.org/10.1016/j.jfms.2003.08.005
- Isaacson PG. The current status of Lymphoma classification. Br J Haematol 2000; 109: 258-66. https://doi.org/10.1046/j.1365-2141.2000.01989.x
- Jacobs RM, Messick JB, Valli VE. Tumors of the hemolymphatic system: lymphoid tumors. In: Tumors in Domestic Animals. 4th ed. Ames: Iowa State Press. 2002:119-198.
- Krenacs L, Himmelmann A, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood 1998; 92: 1308-1316.
- Legendre AM, Krahwinkel DJ, Spaulding KA. Feline nasal and paranasal sinus tumors. J Am Anim Hosp Assoc 1981; 17: 1038-1039.
- Little L, Patel R, Goldschmidt M. Nasal and nasopharyngeal lymphoma in cats: 50 cases (1989-2005). Vet Pathol 2007; 44: 885-892. https://doi.org/10.1354/vp.44-6-885
- Mooney SC, Hayes AA, MacEwen EG, Matus RE, Geary A, Shurgot BA. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981). J Am Vet Med Assoc 1989; 194: 696-702.
- Mukaratirwa S, van der Linde-Sipman JS, Gruys E. Feline nasal and paranasal sinus tumours: clinicopathological study, histomorphological description and diagnostic immunohistochemistry of 123 cases. J Feline Med Surg 2001; 3: 235-245. https://doi.org/10.1053/jfms.2001.0141
- Sfiligoi G, Theon AP, Kent MS. Response of nineteen cats with nasal lymphoma to radiation therapy and chemotherapy. Vet Radiol Ultrasound 2007; 48: 388-393. https://doi.org/10.1111/j.1740-8261.2007.00262.x
- Taylor SS, Goodfellow MR, Browne WJ, Walding B, Murphy S, Tzannes S, Gerou-Ferriani M, Schwartz A, Dobson JM. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats. J Small Anim Pract 2009; 50: 584-592. https://doi.org/10.1111/j.1748-5827.2009.00813.x
- Teske E, van Straten G, van Noort R, Rutteman GR. Chemotherapy with cyclophosphamide, vincristine, and prednisone (COP) in cats with malignant lymphoma: new results with an old protocol. J Vet Intern Med 2002; 16:179-186. https://doi.org/10.1111/j.1939-1676.2002.tb02352.x
- Willmann M, Mullauer L, Guija de Arespacochaga A, Reifinger M, Mosberger I, Thalhammer JG. Pax5 immunostaining in paraffin-embedded sections of canine non-Hodgkin lymphoma: a novel canine pan pre-B- and B-cell marker. Vet Immunol Immunopathol. 2009; 128: 359-365. https://doi.org/10.1016/j.vetimm.2008.11.019